Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
about
Interactions of posaconazole and flucytosine against Cryptococcus neoformansAntifungal Therapy: New Advances in the Understanding and Treatment of MycosisInteraction between posaconazole and amphotericin B in concomitant treatment against Candida albicans in vivoIn vitro and in vivo evidence for amphotericin B as a P-glycoprotein substrate on the blood-brain barrier.Combination therapy with terbinafine and amphotericin B in a rabbit model of experimental invasive aspergillosis.Role of AFR1, an ABC transporter-encoding gene, in the in vivo response to fluconazole and virulence of Cryptococcus neoformans.Interaction between posaconazole and caspofungin in concomitant treatment of mice with systemic Aspergillus infection.Antifungal pharmacotherapy for invasive mould infections.Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90Comparative effectiveness of induction therapy for human immunodeficiency virus-associated cryptococcal meningitis: a network meta-analysis.Toward more effective antifungal therapy: the prospects of combination therapy.Combination treatment of invasive fungal infections.Posaconazole: clinical pharmacology and potential for management of fungal infections.Combination antifungals: an update.Fungicidal versus Fungistatic: what's in a word?In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata.Treatment of refractory feline sporotrichosis with a combination of intralesional amphotericin B and oral itraconazole.Comparison of fractional inhibitory concentration index with response surface modeling for characterization of in vitro interaction of antifungals against itraconazole-susceptible and -resistant Aspergillus fumigatus isolatesPosaconazole and amphotericin B combination therapy against Cryptococcus neoformans infection.Combining two antifungal agents does not enhance survival of Galleria mellonella larvae infected with Madurella mycetomatis.Combined antifungal therapy against systemic murine infections by rare Cryptococcus species.Curcumin enhances the activity of fluconazole against Cryptococcus gattii-induced cryptococcosis infection in mice.Posaconazole: A new agent for the prevention and management of severe, refractory or invasive fungal infections.Dynamic interaction between fluconazole and amphotericin B against Cryptococcus gattii.Posaconazole: An Update of Its Clinical Use.Susceptibility profile of clinical and environmental isolates of Cryptococcus neoformans and Cryptococcus gattii in Uberaba, Minas Gerais, Brazil.Intralesional amphotericin B in a cat with refractory localised sporotrichosis.
P2860
Q28362562-624E1BF3-8E76-48A3-84DE-4E2AB9B7C661Q28818603-5E461E67-829D-4883-A5B7-2157EEE7938EQ33803508-C8B6EBEB-E826-4B19-8103-5B442936B94DQ34058209-6B298A12-D206-4FB7-BA30-7FBC29B92CDDQ34123826-E2E67EC6-6445-4D41-8B60-69503ED32FDBQ34334162-6343479C-F212-4493-AB00-4B97770B6037Q34721750-8ACCD795-A06B-4E48-8D62-4FF0A9DF2085Q35058091-437D75AE-6E2F-4CA6-884F-5872F9069F85Q35102525-D876B02B-B22E-4380-8C68-6EA8227F9753Q35628245-B4382116-02E0-4CC7-9D11-B2FAEC2CF43FQ35828187-AD3D942C-4662-4A86-966E-59F41B1DC786Q36011378-9C75A3D6-25D5-4522-BED5-79055D3620E5Q36233491-7FF4E84D-1C72-4B34-BC14-D818D6B3EA5FQ36960092-7B297294-E141-4164-95F0-19294F3E4834Q37123394-4A16F638-A75B-4A32-8D1A-928F0B8FF7CBQ37489291-0BF81C96-E980-445D-8787-81451B0DD9D7Q39204581-02E055E7-2F76-47FD-85A3-A68AB9C97C61Q39653016-964EB3C8-7CF8-489C-B359-56F01C9338CCQ39955190-08C1BD5A-D081-4F80-A1F4-2A469C1E7052Q40278796-D0FB1BB4-3966-4EA4-980E-A7A62C9C8DD7Q40518953-2F885037-01C5-45ED-9919-6329271AD3F8Q40963460-A5EDABE3-6FA0-4D0B-A9E3-7A97FDE52340Q41848545-F1C879EA-74D8-42F5-8514-E1A111507D62Q42032764-27B2E84A-E13B-431A-8FBC-EB33EB84023AQ42144246-B0B306D8-FC0F-4F1C-876F-4CB477F1E48CQ42277828-CA5B469E-BD9C-468A-A55F-93B466A5CCACQ45954379-67799644-F9AA-4053-8AED-5D0B78BEFCD0
P2860
Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
@ast
Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
@en
type
label
Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
@ast
Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
@en
prefLabel
Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
@ast
Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
@en
P2093
P2860
P1476
Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
@en
P2093
A Giacometti
A M Schimizzi
D Giannini
F Barchiesi
L F Di Francesco
P2860
P304
P356
10.1128/AAC.44.9.2435-2441.2000
P407
P577
2000-09-01T00:00:00Z